2025 Annual Meeting | SS4 - AAN Section Showcase: Autonomic Symptom Assessment and Treatment in Movement Disorders

Date Sunday 04/06/25

Time 03:00 PM - 04:00 PM PDT Add To Calendar

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs

Director(s) Elizabeth A. Coon, MD, FAAN, Indu Subramanian, MD, Abhimanyu Mahajan, MD, MHS, FAAN, Paul Beach, DO, PhD

Topic(s) Autonomic Disorders, Movement Disorders

Learning Objectives Sponsored by the Autonomic Disorders Section. Collaborating sections include the Movement Disorders Section.
This session will discuss both movement disorders and autonomic disorders, highlighting the overlap between autonomics and movement disorders. This program will provide a framework for how best to assess and treat autonomic symptoms in patients with movement disorders. Attendees will learn about the overlap with prodromal symptoms of different movement disorders and use of biomarkers.

CME Available 0.00 CME credit

Event Timeline
03:00 PM - 04:00 PM PDT	Discussion	AAN Section Showcase: Autonomic Symptom Assessment and Treatment in Movement Disorders Elizabeth A. Coon, MD, FAAN, Indu Subramanian, MD, Paul Beach, DO, PhD, Abhimanyu Mahajan, MD, MHS, FAAN

Faculty Disclosures
Elizabeth A. Coon, MD, FAAN	Dr. Coon has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience. Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Indu Subramanian, MD	Dr. Subramanian has nothing to disclose.
Abhimanyu Mahajan, MD, MHS, FAAN	Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima Therapeutics, Inc.. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Mahajan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspen Neuroscience. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adaptive Biosciences . Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement disorders clinical practice. Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Texas Alzheimer's Research And Care Consortium .
Paul Beach, DO, PhD	Dr. Beach has received personal compensation in the range of $0-$499 for serving as a Consultant for BGB Group. Dr. Beach has received personal compensation in the range of $0-$499 for serving as a Consultant for Theravance Biopharma. Dr. Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Beach has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Beach has received research support from National Institutes of Health. Dr. Beach has received research support from National Institutes of Health. Dr. Beach has a non-compensated relationship as a Director at Large with Mission MSA that is relevant to AAN interests or activities.

��ɫ��

��ɫ��